Simona King - 18 Apr 2022 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
Chief Financial Officer
Signature
/s/ Edgar Cale, Attorney-in-Fact
Issuer symbol
PASG
Transactions as of
18 Apr 2022
Net transactions value
$0
Form type
4
Filing time
20 Apr 2022, 16:23:36 UTC
Previous filing
14 Feb 2022
Next filing
15 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Restricted Stock Unit Award $0 +25,000 $0.000000 25,000 18 Apr 2022 Common Stock 25,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F2 1/4 of the RSUs will vest on April 18, 2023, and the remainder will vest as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date.